The CRA pull request that added SECURITY.md, the EU declaration of conformity
and the first README sections was deliberately scoped as phase 1. It covers the
sections that can be generated identically for every extension.
The remaining user-information sections required by Annex II of Regulation
(EU) 2024/2847 need wording specific to this product. The template to follow is
docs/TEMPLATE-README-EN.md in the wv-people/cra repository, which annotates
every section with its Annex II point and states that a section must not be
dropped merely because it is short.
Still to add to README.md:
Points 8.3 to 8.6 and 9 are close to identical across TYPO3 extensions and can
be taken almost verbatim from the template. Points 4.2, 5, 8.1 and 8.2 describe
what this specific extension does and need to be written per product.
Do this on every actively maintained release branch, not only the default one.
The CRA pull request that added
SECURITY.md, the EU declaration of conformityand the first README sections was deliberately scoped as phase 1. It covers the
sections that can be generated identically for every extension.
The remaining user-information sections required by Annex II of Regulation
(EU) 2024/2847 need wording specific to this product. The template to follow is
docs/TEMPLATE-README-EN.mdin thewv-people/crarepository, which annotatesevery section with its Annex II point and states that a section must not be
dropped merely because it is short.
Still to add to
README.md:address, website. web-vision GmbH, An der Eickesmühle 38, 41238
Mönchengladbach, Germany.
if short.
and justify it briefly rather than omitting the section.
Points 8.3 to 8.6 and 9 are close to identical across TYPO3 extensions and can
be taken almost verbatim from the template. Points 4.2, 5, 8.1 and 8.2 describe
what this specific extension does and need to be written per product.
Do this on every actively maintained release branch, not only the default one.